We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Technology Combines, Fuses Cells for Stem Cell Research

By LabMedica International staff writers
Posted on 21 Jan 2009
Engineers have developed a new, highly effective way to pair up cells so they can be fused together into a hybrid cell. More...


The new technique should make it much easier for scientists to study what happens when two cells are combined. For example, fusing an adult cell and an embryonic stem cell allows researchers to study the genetic reprogramming that occurs in such hybrids.

The Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) researchers, led by a collaboration between Dr. Joel Voldman, associate professor of electrical engineering and computer science, and Dr. Rudolf Jaenisch, professor of biology and a member of the Whitehead Institute (Cambridge, MA, USA), reported on the new technique in the January 4, 209, online edition of the journal Nature Methods.

The MIT team's simple but inventive sorting method increases the rate of successful cell fusion from around 10% to roughly 50%, and allows thousands of cell pairings at once. Although cell fusion techniques have been around for a long time, there are many technical limitations, according to Dr. Voldman.

Getting the correct cells to pair up before fusing them is one key hurdle. If scientists are working with a mixture of two cell types, for example A and B, they end up with many AA and BB pairings, as well as the desired AB match. Researchers had earlier trapped cells in tiny cups as they flow across a chip. Each cup can hold only two cells, but there is no way to control whether the cups capture an A and a B, two As or two Bs.

In contrast, the cell-trapping cups on the new sorting device are arranged strategically to capture and pair up cells of different types. First, type A cells are flowed across the chip in one direction and caught in traps that are large enough to hold only one cell. Once the cells are trapped, liquid is flowed across the chip in the opposite direction, pushing the cells out of the small cups and into larger cups across from the small ones. Once one A cell is in each large cup, type B cells are flowed into the large cups. Each cup can only hold two cells, so each ends up with one A and one B. After the cells are paired in the traps, they can be joined together by an electric pulse that fuses the cell membranes.

In addition to helping with studies of stem cell reprogramming, this technique could be used to examine interactions between any types of cells. "It's a very general type of device,” said Dr. Voldman.

Related Links:
Massachusetts Institute of Technology




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.